These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 6978549

  • 1. Assessment of the interaction of warfarin with aspirin and dipyridamole.
    Donaldson DR, Sreeharan N, Crow MJ, Rajah SM.
    Thromb Haemost; 1982 Feb 26; 47(1):77. PubMed ID: 6978549
    [No Abstract] [Full Text] [Related]

  • 2. Drug trials in prevention of occlusion of aorta--coronary artery vein grafts.
    Chesebro JH, Fuster V.
    J Thorac Cardiovasc Surg; 1982 Jan 26; 83(1):90-3. PubMed ID: 7033674
    [No Abstract] [Full Text] [Related]

  • 3. Warfarin versus dipyridamole-aspirin and pentoxifylline-aspirin for the prevention of prosthetic heart valve thromboembolism: a prospective randomized clinical trial.
    Mok CK, Boey J, Wang R, Chan TK, Cheung KL, Lee PK, Chow J, Ng RP, Tse TF.
    Circulation; 1985 Nov 26; 72(5):1059-63. PubMed ID: 3899404
    [Abstract] [Full Text] [Related]

  • 4. The role of dipyridamole in the therapy of vascular disease.
    Green D, Miller V.
    Geriatrics; 1993 Jan 26; 48(1):46, 51-3, 57-8. PubMed ID: 8419269
    [Abstract] [Full Text] [Related]

  • 5. Dipyridamole-aspirin as thromboembolic prophylaxis in patients with aortic valve prosthesis. Prospective study with the Model 2320 Starr-Edwards prosthesis.
    Brott WH, Zajtchuk R, Bowen TE, Davia J, Green DC.
    J Thorac Cardiovasc Surg; 1981 Apr 26; 81(4):632-5. PubMed ID: 7206773
    [Abstract] [Full Text] [Related]

  • 6. Dipyridamole and aspirin and patency of coronary bypass grafts.
    von Schacky C.
    N Engl J Med; 1984 Jun 07; 310(23):1533-4. PubMed ID: 6609308
    [No Abstract] [Full Text] [Related]

  • 7. Coronary artery bypass and antiplatelet therapy.
    Copeland JG, Goldman S.
    Ariz Med; 1984 Apr 07; 41(4):223-5. PubMed ID: 6611146
    [No Abstract] [Full Text] [Related]

  • 8. Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole.
    Chesebro JH, Fuster V, Elveback LR, McGoon DC, Pluth JR, Puga FJ, Wallace RB, Danielson GK, Orszulak TA, Piehler JM, Schaff HV.
    Am J Cardiol; 1983 May 15; 51(9):1537-41. PubMed ID: 6342354
    [Abstract] [Full Text] [Related]

  • 9. [No benefit in the addition of dipyridamole to, nor of anticoagulants in comparison to, a low dose of acetylsalicylic acid (50 mg) in the prevention of venous transplant stenosis following coronary bypass surgery].
    Loeliger EA.
    Ned Tijdschr Geneeskd; 1993 Dec 18; 137(51):2669. PubMed ID: 8278004
    [No Abstract] [Full Text] [Related]

  • 10. Antiplatelet and anticoagulant therapy after coronary bypass.
    Phillips SJ, Kongtahworn C, Zeff RH, Beshany SE.
    N Engl J Med; 1980 Apr 10; 302(15):866. PubMed ID: 6965762
    [No Abstract] [Full Text] [Related]

  • 11. Use of common antiplatelet drugs for vascular diseases.
    Pagano T, Nair CK, Sketch MH.
    Geriatrics; 1983 Nov 10; 38(11):75-95. PubMed ID: 6605278
    [No Abstract] [Full Text] [Related]

  • 12. Aspirin and dipyridamole reduce lipid accumulation in vein bypass grafts: combination versus single drug therapy.
    Boerboom LE, Olinger GN, Bonchek LI, Kissebah AH.
    Adv Prostaglandin Thromboxane Leukot Res; 1985 Nov 10; 13():315-7. PubMed ID: 3159218
    [No Abstract] [Full Text] [Related]

  • 13. Warfarin and aspirin after heart-valve replacement.
    Cannegieter SC, van der Meer FJ, Briët E, Rosendaal FR.
    N Engl J Med; 1994 Feb 17; 330(7):507-8; author reply 508-9. PubMed ID: 8289864
    [No Abstract] [Full Text] [Related]

  • 14. [Pregnancy in patients with 2 heart prostheses and antithrombotic drug therapy. Report of 2 cases].
    Ibarra-Pérez C, Alvarez de la Cadena O, Portillo-Pérez S, Noriega-Guerra L.
    Ginecol Obstet Mex; 1976 Jul 17; 40(237):53-60. PubMed ID: 950147
    [No Abstract] [Full Text] [Related]

  • 15. Low dose anticoagulation after St. Jude Medical prosthesis implantation in patients under 18 years of age.
    Yamak B, Sener E, Kiziltepes U, Gol K, Tarcan O, Mavitas B, Tasdemir O, Bayazit K.
    J Heart Valve Dis; 1995 May 17; 4(3):274-8. PubMed ID: 7655688
    [Abstract] [Full Text] [Related]

  • 16. Comparison of anticoagulation regimens after Carpentier-Edwards aortic or mitral valve replacement.
    Blair KL, Hatton AC, White WD, Smith LR, Lowe JE, Wolfe WG, Young WG, Oldham HN, Douglas JM, Glower DD.
    Circulation; 1994 Nov 17; 90(5 Pt 2):II214-9. PubMed ID: 7955256
    [Abstract] [Full Text] [Related]

  • 17. Dipyridamole: an unfulfilled promise?
    Hillis GS, Jennings KP.
    Cardiovasc Surg; 1997 Aug 17; 5(4):350-3. PubMed ID: 9350787
    [No Abstract] [Full Text] [Related]

  • 18. Late incidence and determinants of stroke after aortic and mitral valve replacement.
    Ruel M, Masters RG, Rubens FD, Bédard PJ, Pipe AL, Goldstein WG, Hendry PJ, Mesana TG.
    Ann Thorac Surg; 2004 Jul 17; 78(1):77-83; discussion 83-4. PubMed ID: 15223407
    [Abstract] [Full Text] [Related]

  • 19. Registry of prospective clinical trials--fifth report.
    Verstraete M.
    Thromb Haemost; 1982 Dec 27; 48(3):334-8. PubMed ID: 6761891
    [No Abstract] [Full Text] [Related]

  • 20. Comparing warfarin to aspirin (WoA) after aortic valve replacement with the St. Jude Medical Epic heart valve bioprosthesis: results of the WoA Epic pilot trial.
    Colli A, Mestres CA, Castella M, Gherli T.
    J Heart Valve Dis; 2007 Nov 27; 16(6):667-71. PubMed ID: 18095518
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.